Sickle cell breakthrough? drug combo aims to raise hemoglobin
Disease control
Completed
This early-phase study tested whether adding erythropoietin (EPO) to standard hydroxyurea treatment can safely raise hemoglobin levels in adults with sickle cell disease. Seventeen participants with chronic anemia received the combination for 12 weeks. The main goal was to see if…
Phase: PHASE1, PHASE2 • Sponsor: Julia Xu • Aim: Disease control
Last updated May 10, 2026 06:14 UTC